Tweenvest Stocks

Guangdong Hybribio Biotech Co.,Ltd. (SZSE: 300639)

Health Care · Biotechnology · CN

CN¥6.14

-2.07% today · +9.6% 1Y

Guangdong Hybribio Biotech Co.,Ltd. (SZSE: 300639) operates in the Biotechnology industry within the Health Care sector. The company is valued at $575.67M and employs 1,990 people.

Over the last twelve months the share price has gained 9.6%, trading between 4.75 and 10.07.

Tweenvest scores Guangdong Hybribio Biotech Co.,Ltd. across four factors: quality 67/100, value 37/100, growth 33/100. Its strongest factor is quality.

300639 price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$575.67M
Revenue (TTM)
$96.38M
P/E
—
EPS
-0.02
Dividend yield
—
Beta (5Y)
0.45
52-week high
CN¥10.07
52-week low
CN¥4.75
Avg volume (3M)
—
Shares outstanding
627.62M
Employees
1,990
Next earnings
—

About Guangdong Hybribio Biotech Co.,Ltd.

Guangdong Hybribio Biotech Co., Ltd. engages in the research, development, production, and sale of nucleic acid molecular diagnostic products in China. It also provides on-site technical training and after-sales technical service support. The company was founded by Qiao Zhong Guan on June 13, 2003 and is headquartered in Chaozhou, China.

ISIN
CNE100002N51
Founded
2003
Listed since
Apr 13, 2017
Exchange
Shenzhen Stock Exchange
Currency
CNY
CompanyMarket capPriceDay
Silence Therapeutics plcNasdaqGM: SLN$593.66M$9.65-2.13%
Medicalsystem Biotechnology Co., LtdSZSE: 300439$591.56MCN¥10.31+0.59%
Blau Farmacêutica S.A.BOVESPA: BLAU3$584.71MR$12.61+16.54%
Landfar Bio-medicine Co., LtdSZSE: 000504$580.91MCN¥11.79-5.07%
Pharmicell Co., Ltd.KOSE: A005690$573.98M₩12,860.00+3.71%
Shanghai Serum Bio-Technology Co., Ltd.SHSE: 688163$563.39MCN¥34.87-12.83%
Shanghai MicuRx Pharmaceutical Co., Ltd.SHSE: 688373$561.38MCN¥5.73-0.87%
Zhejiang Orient Gene Biotech Co., LtdSHSE: 688298$557.20MCN¥19.50+0.67%

Browse every Biotechnology company →

Figures last refreshed Oct 11, 2026.